Abstract:Metastatic recurrence following curative-intent pancreatic cancer surgery is a major clinical problem as nearly all die of this at both early and latent periods following surgery. Latent recurrences are due to reactivation of dormant tumor cells that disseminate before the primary tumor has been removed. The mechanisms that drive cancer dormancy are poorly understood in part because of the lack of animal models that recapitulate the biology of the resected patient. Here we introduce a novel mouse model of pancreatic cancer dormancy in which we establish distal pancreatic tumors by orthotopic injection, resect them four weeks later and then follow the mice for recurrence. We observed recurrence patterns and survival outcomes that mimic human patients undergoing surgery for pancreatic cancer where two thirds of the mice succumb to early metastatic recurrence (median survival 26 days) and one third of the mice (called dormant mice) live substantially long (median survival 554 days) without clinical evidence of disease yet harbor disseminated tumor cells in most organs of the body. Disseminated tumor cells isolated from the livers of dormant mice were quiescent, exhibited stem cell properties and upregulated the expression of Dec2, a transcriptional repressor previously best known for its importance in maintaining circadian rhythms. Dec2 enabled the dormant tumor cells to evade the immune system by reducing the amount of MHC1 on their surfaces, and thereby lowered the number of CD8+ T cells within the tumor microenvironment. Knocking out Dec2 significantly improved the overall survival of immunocompetent mice and increased CD8+ T cell tumor infiltration. The decrease in cell surface MHCI was likely due to impaired surface localization of the protein. RNA-seq analysis demonstrated a loss of antigen presentation pathway genes in Dec2 WT cells, particularly in genes encoding subunits of the proteasome. Proper localization of MHC1 is known to depend upon proteasome-generated peptides. By cut-and-run analysis, Dec2 bound directly to the promoters of a number of proteasomal genes, lowered expression of these genes, and decreased proteasomal activity. These studies describe a new mechanism for Dec2 in regulating cancer dormancy through its downregulation of proteasomal activity which in turn converts a hot to a cold TME by decreasing cell surface MHC1. Citation Format: Lan Wang, Orjola Prela, Ching-Hua Shih, Juliana Cazarin de Menezes, Brian Altman, Paula Vertino, Chris Harris, Darren Carpizo. The circadian rhythm gene Dec2 promotes pancreatic cancer dormancy by facilitating immune evasion [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Pancreatic Cancer; 2023 Sep 27-30; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(2 Suppl) nr C033.

Cancer-associated fibroblasts-derived CXCL1 activates DEC2-mediated dormancy in oral squamous cell carcinoma

Cancer-Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin

Inhibition of DEC2 is necessary for exiting cell dormancy in salivary adenoid cystic carcinoma

Diminished CD68+ Cancer-Associated Fibroblast Subset Induces Regulatory T-Cell (treg) Infiltration and Predicts Poor Prognosis of Oral Squamous Cell Carcinoma Patients.

Hypoxia-Induced Senescent Fibroblasts Secrete IGF1 to Promote Cancer Stemness in Esophageal Squamous Cell Carcinoma

CAFs-derived lactate enhances the cancer stemness through inhibiting the MST1 ubiquitination degradation in OSCC

Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-β/Smad pathway

Cancer-Associated Fibroblasts Contribute to Oral Cancer Cells Proliferation and Metastasis Via Exosome-Mediated Paracrine MiR-34a-5p

Interaction between CAFs and apoptotic cancer cells promotes OSCC proliferation via STING signaling

CAF-secreted CXCL1 conferred radioresistance by regulating DNA damage response in a ROS-dependent manner in esophageal squamous cell carcinoma

CAFs-Secreted CXCL1 Mediated Radioresistance by Regulating DNA Damage Response in an ROS-Dependent Manner in Esophageal Squamous Cell Carcinoma

Interferon-α Promotes the Expression of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma

lncRNA DCST1-AS1 Facilitates Oral Squamous Cell Carcinoma by Promoting M2 Macrophage Polarization through Activating NF-κB Signaling

Abstract C033: The circadian rhythm gene Dec2 promotes pancreatic cancer dormancy by facilitating immune evasion

Cancer-associated fibroblasts promote tumor progression by lncRNA-mediated RUNX2/GDF10 signaling in oral squamous cell carcinoma

Differentiated embryo chondrocyte 1, induced by hypoxia-inducible factor 1α, promotes cell migration in oral squamous cell carcinoma cell lines.

Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma

Cancer-Associated Fibroblasts Modulate Transcriptional Signatures Involved in Proliferation, Differentiation and Metastasis in Head and Neck Squamous Cell Carcinoma

Cancer associated fibroblasts serve as an ovarian cancer stem cell niche through noncanonical Wnt5a signaling

Forkhead Box D1 Promotes EMT and Chemoresistance by Upregulating Lncrna CYTOR in Oral Squamous Cell Carcinoma

Abstract 5624: Dec2, a circadian rhythm gene facilitates pancreatic cancer dormancy through evasion of antitumor immunity